Vital Care Express

stethoscopeNeurology

The latest neurology news and research from Vital Care Express, with the questions patients and clinicians actually ask.

A once-daily pill cut MS relapses in two big trials, but Novartis is holding the exact numbers back

Novartis says its oral BTK inhibitor remibrutinib beat a standard MS pill on relapses and showed no liver safety signal in the Phase III REMODEL trials, with full data still to come

A new review says neurocritical care is advancing fast. It forgets to show the numbers

The paper tours shiny ICU gadgets and tighter treatment targets, but never says whether any of them help patients live longer or recover better

Brain-spine interfaces help paralyzed patients walk, but the headlines skip the hard parts

A 2023 trial shows six patients regained leg movement, but global data reveals a 23 per million yearly incidence and a dangerous shift toward older patients.